MGNX — MacroGenics Balance Sheet
0.000.00%
Last trade - 00:00
- $232.07m
- $91.70m
- $58.75m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 216 | 273 | 244 | 154 | 230 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12.7 | 23.1 | 10.4 | 56.2 | 10.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 240 | 313 | 280 | 222 | 251 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 48.2 | 61.4 | 54.3 | 56.9 | 45.7 |
Other Long Term Assets | |||||
Total Assets | 313 | 379 | 335 | 280 | 298 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 45.2 | 50.7 | 74.6 | 48.6 | 56.1 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 81.9 | 82.9 | 95.6 | 138 | 146 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 231 | 296 | 240 | 142 | 153 |
Total Liabilities & Shareholders' Equity | 313 | 379 | 335 | 280 | 298 |
Total Common Shares Outstanding |